Recurrence Score testing does not appear to benefit patients with grade 1, progesterone receptor positive breast cancers: An opportunity to eliminate over-treatment and decrease testing costs.

ALERT: A cyber incident at Optum/Change Healthcare may delay Luminis Health bill processing. Watch for fraud and verify any concerning messages with your provider's office. We are working to minimize disruptions.

Primary Author not in Drupal

Udai Sibia

Secondary Author not in Drupal

Tom Sanders

Third Author not in Drupal

Charles Mylander

Title of the Project

Recurrence Score testing does not appear to benefit patients with grade 1, progesterone receptor positive breast cancers: An opportunity to eliminate over-treatment and decrease testing costs.

Service Line not in Drupal

Surgery

Format of the Project

Journal Article

Affiliated Specialties not in Drupal

Breast

Name of Publication

Hematology/Oncology and Stem Cell Therapy